Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    HCA Healthcare Inc.

    NYSE: HCA · Real-Time Price · USD
    395.77
    2.12 (0.54%)
    At close: Aug 15, 2025, 3:59 PM
    395.36
    -0.10%
    After-hours: Aug 15, 2025, 06:06 PM EDT

    HCA Healthcare Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 72.7B 71.58B 70.6B 69.62B 68.35B 66.72B 64.97B 63.16B 61.92B 60.88B 60.23B 59.8B 60.1B 59.72B 58.75B 57.98B 56.02B 52.65B
    Cost of Revenue
    		 61.62B 60.74B 60.06B 59.12B 58.16B 56.96B 55.34B 53.92B 52.63B 51.59B 51.18B 50.77B 50.75B 50.17B 49.07B 48.24B 46.61B 44.57B
    Gross Profit
    		 11.08B 10.84B 10.55B 10.5B 10.18B 9.75B 9.63B 9.24B 9.29B 9.29B 9.05B 9.03B 9.36B 9.54B 9.68B 9.74B 9.41B 8.08B
    Operating Income
    		 11.08B 10.84B 10.55B 10.5B 10.18B 9.75B 9.63B 9.24B 9.29B 9.29B 9.05B 9.03B 9.36B 9.54B 9.68B 9.74B 9.41B 8.08B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 8.78B 8.6B 8.52B 8.73B 8.46B 8.03B 7.71B 8.66B 8.74B 8.69B 8.58B 7.86B 9.32B 9.67B 9.83B 9.32B 7.15B 6.59B
    Net Income
    		 5.97B 5.78B 5.76B 5.93B 5.74B 5.47B 5.24B 5.72B 5.77B 5.73B 5.64B 5.38B 6.51B 6.81B 6.96B 6.57B 4.97B 4.6B
    Selling & General & Admin
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Interest Expense
    		 2.16B 2.1B 2.06B 2.02B 1.99B 1.97B 1.94B 1.9B 1.86B 1.81B 1.74B 1.67B 1.61B 1.56B 1.55B 1.53B 1.52B 1.52B
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 61.62B 60.74B 60.06B 59.12B 58.16B 56.96B 55.34B 53.92B 52.63B 51.59B 51.18B 50.77B 50.75B 50.17B 49.07B 48.24B 46.61B 44.57B
    Income Tax Expense
    		 1.9B 1.92B 1.87B 1.9B 1.83B 1.68B 1.61B 1.79B 1.79B 1.78B 1.75B 1.67B 2B 2.07B 2.11B 1.91B 1.43B 1.32B
    Shares Outstanding (Basic)
    		 241.91M 249.44M 252.3M 259.92M 263.22M 263.22M 265.54M 271.17M 274.49M 276.91M 277.38M 285.96M 292.53M 302.45M 305.48M 318.07M 328.17M 338.12M
    Shares Outstanding (Diluted)
    		 241.91M 249.44M 255.31M 259.92M 264.07M 268.02M 271.19M 275.42M 278.2M 280.96M 285.66M 289.85M 296.06M 307.37M 315.42M 324.03M 332.61M 343.32M
    EPS (Basic)
    		 24.16 22.76 22.28 22.63 21.67 20.42 19.30 20.75 20.74 20.34 19.63 18.07 21.23 21.70 21.70 19.96 14.80 13.57
    EPS (Diluted)
    		 23.80 22.50 21.99 22.29 21.32 20.08 18.99 20.34 20.33 19.94 19.23 17.70 20.79 21.25 21.25 19.63 14.58 13.38
    EBITDA
    		 14.36B 14.08B 13.9B 14B 13.62B 13.12B 12.72B 13.6B 13.62B 13.49B 13.29B 12.48B 13.85B 14.12B 14.23B 13.64B 11.44B 10.86B
    EBIT
    		 10.94B 10.7B 10.58B 10.76B 10.45B 10B 9.64B 10.56B 10.6B 10.5B 10.32B 9.54B 10.93B 11.23B 11.38B 10.85B 8.67B 8.12B
    Depreciation & Amortization
    		 3.42B 3.38B 3.31B 3.25B 3.17B 3.12B 3.08B 3.04B 3.02B 2.99B 2.97B 2.95B 2.91B 2.89B 2.85B 2.79B 2.77B 2.74B

    Add to Watchlist